Share:
Peer-Reviewed Publication
Clin Nutr ESPEN2024;63572-584.October 1, 2024Journal Article

Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer - A validation study.

Karel C Smit1, Jeroen W G Derksen2, Sophie A Kurk1, Pim Moeskops3, Miriam Koopman4, Wouter B Veldhuis5, Anne M May6
1Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA, Utrecht, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA, Utrecht, the Netherlands.
2Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA, Utrecht, the Netherlands.
3Quantib, Westblaak 130, 3012 KM Rotterdam, the Netherlands.
4Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA, Utrecht, the Netherlands.
5Department of Radiology, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA, Utrecht, the Netherlands.
6Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA, Utrecht, the Netherlands. Electronic address: a.m.may@umcutrecht.nl.

Abstract

BACKGROUND: Low muscle mass and skeletal muscle mass (SMM) loss are associated with adverse patient outcomes, but the time-consuming nature of manual SMM quantification prohibits implementation of this metric in clinical practice. Therefore, we assessed the feasibility of automated SMM quantification compared to manual quantification. We evaluated both diagnostic accuracy for low muscle mass and a…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.